Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines ar...
Source: MMWR Recomm Rep - August 27, 2021 Category: Epidemiology Authors: Lisa A Grohskopf Elif Alyanak Jill M Ferdinands Karen R Broder Lenee H Blanton H Keipp Talbot Alicia M Fry Source Type: research

Sexually Transmitted Infections Treatment Guidelines, 2021
MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. doi: 10.15585/mmwr.rr7004a1.ABSTRACTThese guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11-14, 2019. The information in this report updates the 2015 guidelines. These guidelines discuss 1) updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; 2) addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease...
Source: MMWR Recomm Rep - July 22, 2021 Category: Epidemiology Authors: Kimberly A Workowski Laura H Bachmann Philip A Chan Christine M Johnston Christina A Muzny Ina Park Hilary Reno Jonathan M Zenilman Gail A Bolan Source Type: research

Sexually Transmitted Infections Treatment Guidelines, 2021
MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. doi: 10.15585/mmwr.rr7004a1.ABSTRACTThese guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11-14, 2019. The information in this report updates the 2015 guidelines. These guidelines discuss 1) updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; 2) addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease...
Source: MMWR Recomm Rep - July 22, 2021 Category: Epidemiology Authors: Kimberly A Workowski Laura H Bachmann Philip A Chan Christine M Johnston Christina A Muzny Ina Park Hilary Reno Jonathan M Zenilman Gail A Bolan Source Type: research

Sexually Transmitted Infections Treatment Guidelines, 2021
MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. doi: 10.15585/mmwr.rr7004a1.ABSTRACTThese guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11-14, 2019. The information in this report updates the 2015 guidelines. These guidelines discuss 1) updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; 2) addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease...
Source: MMWR Recomm Rep - July 22, 2021 Category: Epidemiology Authors: Kimberly A Workowski Laura H Bachmann Philip A Chan Christine M Johnston Christina A Muzny Ina Park Hilary Reno Jonathan M Zenilman Gail A Bolan Source Type: research

Sexually Transmitted Infections Treatment Guidelines, 2021
MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. doi: 10.15585/mmwr.rr7004a1.ABSTRACTThese guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11-14, 2019. The information in this report updates the 2015 guidelines. These guidelines discuss 1) updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; 2) addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease...
Source: MMWR Recomm Rep - July 22, 2021 Category: Epidemiology Authors: Kimberly A Workowski Laura H Bachmann Philip A Chan Christine M Johnston Christina A Muzny Ina Park Hilary Reno Jonathan M Zenilman Gail A Bolan Source Type: research

Sexually Transmitted Infections Treatment Guidelines, 2021
MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. doi: 10.15585/mmwr.rr7004a1.ABSTRACTThese guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11-14, 2019. The information in this report updates the 2015 guidelines. These guidelines discuss 1) updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; 2) addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease...
Source: MMWR Recomm Rep - July 22, 2021 Category: Epidemiology Authors: Kimberly A Workowski Laura H Bachmann Philip A Chan Christine M Johnston Christina A Muzny Ina Park Hilary Reno Jonathan M Zenilman Gail A Bolan Source Type: research

Sexually Transmitted Infections Treatment Guidelines, 2021
MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. doi: 10.15585/mmwr.rr7004a1.ABSTRACTThese guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11-14, 2019. The information in this report updates the 2015 guidelines. These guidelines discuss 1) updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; 2) addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease...
Source: MMWR Recomm Rep - July 22, 2021 Category: Epidemiology Authors: Kimberly A Workowski Laura H Bachmann Philip A Chan Christine M Johnston Christina A Muzny Ina Park Hilary Reno Jonathan M Zenilman Gail A Bolan Source Type: research

Sexually Transmitted Infections Treatment Guidelines, 2021
MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. doi: 10.15585/mmwr.rr7004a1.ABSTRACTThese guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11-14, 2019. The information in this report updates the 2015 guidelines. These guidelines discuss 1) updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; 2) addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease...
Source: MMWR Recomm Rep - July 22, 2021 Category: Epidemiology Authors: Kimberly A Workowski Laura H Bachmann Philip A Chan Christine M Johnston Christina A Muzny Ina Park Hilary Reno Jonathan M Zenilman Gail A Bolan Source Type: research

Sexually Transmitted Infections Treatment Guidelines, 2021
MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. doi: 10.15585/mmwr.rr7004a1.ABSTRACTThese guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11-14, 2019. The information in this report updates the 2015 guidelines. These guidelines discuss 1) updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; 2) addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease...
Source: MMWR Recomm Rep - July 22, 2021 Category: Epidemiology Authors: Kimberly A Workowski Laura H Bachmann Philip A Chan Christine M Johnston Christina A Muzny Ina Park Hilary Reno Jonathan M Zenilman Gail A Bolan Source Type: research

Sexually Transmitted Infections Treatment Guidelines, 2021
MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. doi: 10.15585/mmwr.rr7004a1.ABSTRACTThese guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11-14, 2019. The information in this report updates the 2015 guidelines. These guidelines discuss 1) updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; 2) addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease...
Source: MMWR Recomm Rep - July 22, 2021 Category: Epidemiology Authors: Kimberly A Workowski Laura H Bachmann Philip A Chan Christine M Johnston Christina A Muzny Ina Park Hilary Reno Jonathan M Zenilman Gail A Bolan Source Type: research

Sexually Transmitted Infections Treatment Guidelines, 2021
MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. doi: 10.15585/mmwr.rr7004a1.ABSTRACTThese guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11-14, 2019. The information in this report updates the 2015 guidelines. These guidelines discuss 1) updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; 2) addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease...
Source: MMWR Recomm Rep - July 22, 2021 Category: Epidemiology Authors: Kimberly A Workowski Laura H Bachmann Philip A Chan Christine M Johnston Christina A Muzny Ina Park Hilary Reno Jonathan M Zenilman Gail A Bolan Source Type: research

Sexually Transmitted Infections Treatment Guidelines, 2021
MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. doi: 10.15585/mmwr.rr7004a1.ABSTRACTThese guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11-14, 2019. The information in this report updates the 2015 guidelines. These guidelines discuss 1) updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; 2) addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease...
Source: MMWR Recomm Rep - July 22, 2021 Category: Epidemiology Authors: Kimberly A Workowski Laura H Bachmann Philip A Chan Christine M Johnston Christina A Muzny Ina Park Hilary Reno Jonathan M Zenilman Gail A Bolan Source Type: research

Sexually Transmitted Infections Treatment Guidelines, 2021
MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. doi: 10.15585/mmwr.rr7004a1.ABSTRACTThese guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11-14, 2019. The information in this report updates the 2015 guidelines. These guidelines discuss 1) updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; 2) addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease...
Source: MMWR Recomm Rep - July 22, 2021 Category: Epidemiology Authors: Kimberly A Workowski Laura H Bachmann Philip A Chan Christine M Johnston Christina A Muzny Ina Park Hilary Reno Jonathan M Zenilman Gail A Bolan Source Type: research

Sexually Transmitted Infections Treatment Guidelines, 2021
MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. doi: 10.15585/mmwr.rr7004a1.ABSTRACTThese guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11-14, 2019. The information in this report updates the 2015 guidelines. These guidelines discuss 1) updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; 2) addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease...
Source: MMWR Recomm Rep - July 22, 2021 Category: Epidemiology Authors: Kimberly A Workowski Laura H Bachmann Philip A Chan Christine M Johnston Christina A Muzny Ina Park Hilary Reno Jonathan M Zenilman Gail A Bolan Source Type: research

Sexually Transmitted Infections Treatment Guidelines, 2021
MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. doi: 10.15585/mmwr.rr7004a1.ABSTRACTThese guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11-14, 2019. The information in this report updates the 2015 guidelines. These guidelines discuss 1) updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; 2) addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease...
Source: MMWR Recomm Rep - July 22, 2021 Category: Epidemiology Authors: Kimberly A Workowski Laura H Bachmann Philip A Chan Christine M Johnston Christina A Muzny Ina Park Hilary Reno Jonathan M Zenilman Gail A Bolan Source Type: research